S 4066
Safeguarding Women from Chemical Abortion Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:44 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Safeguarding Women from Chemical Abortion Act, aims to restrict the use of mifepristone, a drug used in medication abortion. It seeks to effectively revoke the FDA’s approval for mifepristone’s use in terminating pregnancies, establish a federal tort liability for harm caused by these drugs, and create a private right of action for individuals seeking compensation for injuries or mental health harm resulting from their use. The bill also defines key terms related to the medication and its manufacturers.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.